On June 18, 2025, the U.S. Supreme Court ruled 6–3 in United States v. Skrmetti, upholding Tennessee’s ban—SB 1—on gender-affirming medical treatments for minors, such as puberty blockers and hormone therapy (thecut.com).
Contents
🔍 What led to this decision?
- Tennessee’s SB 1 (2023) prohibits doctors from prescribing puberty blockers or hormone therapy to minors for gender transition, though these treatments remain allowed for other medical conditions like precocious puberty (en.wikipedia.org).
- Plaintiffs—including a Memphis provider, two families, and a teen known as L.W.—argued the law discriminates against transgender youth, violating the 14th Amendment’s Equal Protection Clause (thecut.com).
⚖️ Ruling Highlights
- Majority Opinion (Chief Justice Roberts): The Court determined SB 1 didn’t classify based on sex or transgender status but instead regulated based on medical purpose and age. They applied rational basis review—not a stricter standard—and said deciding medical policy is up to legislatures, not the courts (en.wikipedia.org).
- Dissent (Justices Sotomayor, Kagan & Jackson): Sotomayor warned that the decision “invites legislatures to engage in discrimination by hiding blatant sex classifications in plain sight,” and that it deepens a harmful environment for transgender children (en.wikipedia.org).
🧭 What It Means
| Category | Impact |
|---|---|
| Trans youth in banned states | Still cannot access care locally—families must consider travel for treatment (thecut.com) |
| Trans youth in allowed states | Unaffected—no nationwide ban resulted from this ruling |
| Trans adults | No changes—adult access isn’t touched by this decision |
| Other anti-trans laws | Future legal challenges (parental rights, bathroom/sports bans, etc.) remain possible |
⚠️ Broader Effects
- The ruling signals a setback for transgender equality, but medical organizations—like the AMA and APA—continue to affirm that gender-affirming care is safe and often life-saving (thedailybeast.com).
- The legal environment remains volatile: 25–27 states have similar bans, and the federal government, now under Trump, has issued orders restricting trans medical care and federal benefits for those under 19, although some are temporarily blocked in court .
- Advocates emphasize that this is far from the end of the road—ongoing challenges grounded in parental rights, bodily autonomy, and advocacy efforts will continue .
🗣️ Voices from the Front Lines
- Chase Strangio (ACLU): Called the decision “a devastating loss,” but vowed continued legal efforts to defend trans youth (aclu.org).
- Sotomayor (dissent): Warned the Court is stripping rights from “transgender children and the parents and families who love them” (thedailybeast.com).
- Tennessee AG Skrmetti: Framed the ruling as a return of power from courts to elected officials (en.wikipedia.org).
- Medical groups: Strongly affirmed the importance of gender-affirming treatments and pleaded for family autonomy (en.wikipedia.org).
🧭 What Comes Next?
- This decision doesn’t close legal doors—challenges based on discrimination, parental rights, and federal protections are in motion.
- Expect further court battles over related bans (e.g., in sports, schools, IDs).
- Meanwhile, trans youth and families in restrictive states may seek out-of-state care or consider relocating to access essential medical support.
✏️ Final Takeaway
The Skrmetti ruling marks a serious blow for transgender young people, especially in states with bans. While it doesn’t extend nationwide, it reaffirms the power of state legislatures over courts in setting medical policy. The fight for trans rights, however, is far from over—legal action, medical advocacy, and community support continue to play pivotal roles.
